| Cell line name |
NZM029 |
|---|
| Synonyms |
NZM29 |
|---|
| Accession |
CVCL_S434 |
|---|
| Resource Identification Initiative |
To cite this cell line use: NZM029 (RRID:CVCL_S434) |
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): PubMed=32567790
Markers:| Amelogenin | X,Y |
| CSF1PO | 11 |
| D2S1338 | 17 |
| D3S1358 | 16,18 |
| D5S818 | 12 |
| D7S820 | 10,11 |
| D8S1179 | 12,13 |
| D13S317 | 11 |
| D16S539 | 11,13 |
| D18S51 | 16,18 |
| D19S433 | 13,14 |
| D21S11 | 31,32 |
| FGA | 19,24 |
| TH01 | 8,9.3 |
| TPOX | 8,9 |
| vWA | 18,19 |
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=23658559; DOI=10.3389/fgene.2013.00066; PMCID=PMC3647113
Stones C.J., Kim J.E., Joseph W.R., Leung E.Y., Marshall E.S., Finlay G.J., Shelling A.N., Baguley B.C.
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.
Front. Genet. 4:66.1-66.6(2013) PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249
Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J., Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S., Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: a valuable model for studying the impact of genetic diversity in melanoma.
Pigment Cell Melanoma Res. 34:136-143(2021) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54931560
|
|---|
| Polymorphism and mutation databases |
Cosmic; 2007663
|
|---|
| Entry history |
|---|
| Entry creation | 05-Nov-2013 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 7 |
|---|
